Clinical trial
Circulating Tumor DNA in Surgical Lung Cancer Patients
NCT03081741
Study timeline
Study start (actual)2017-05-03Date precision: day
Registry last updated2017-05-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Neoplasmsunresolved
Interventions
Sponsors & collaborators
Shenzhen Gene Health Bio Tech Co., Ltd.lead sponsor
Shenzhen People's Hospitalcollaborator
Shenzhen Second People's Hospitalcollaborator
Peking University Shenzhen Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03081741 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.